Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1842 of 6351
-
Ancient herbal mix put to the test against COVID-19
Disease control Recruiting nowThis is a randomized, double-blinded, placebo-controlled clinical trial. This study is to evaluate the effectiveness and safety of Yinqiaosan-Maxingganshitang in the treatment of the major symptoms of mild and moderate COVID-19 patients by telemedicine.
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Lupus drug anifrolumab put to the test in everyday patients
Disease control Recruiting nowBACKGROUND AND RATIONALE. The role of type I interferons (IFN) in innate and adaptive immunity has been extensively studied, establishing a key role for type I IFNs in immune homeostasis. With growing evidence that type I IFNs play an important role in autoimmune diseases, inhibi…
Sponsor: University of Pisa • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Smartwatch coaching boosts activity in spinal cord injury patients
Symptom relief Recruiting nowThe overarching goal of this research study is to evaluate a sensor-enabled, just-in-time adaptive intervention (JITAI) strategy to increase and sustain physical activity levels among individuals with spinal cord injury (SCI) in their communities. A primary objective of this stud…
Phase 2 • Sponsor: Temple University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New hope for tough thyroid cancers? cabozantinib trial shows promise
Disease control CompletedCABOTHYROID is a prospective, exploratory, biomarker-focused, phase II, single-arm, non-randomized, non-blinded, investigator-initiated study of cabozantinib in patients with previously treated advanced radioactive-iodine refractory
Phase 2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Sickle cell hope: drug combo raises hemoglobin in early trial
Disease control CompletedThe proposed study is a Phase 1/2 multi-center study evaluating the safety and efficacy of erythropoietin (EPO) in combination with hydroxyurea in the treatment of chronic anemia in patients with sickle cell disease (SCD).
Phase 1/2 • Sponsor: Julia Xu • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New imaging agent could reveal which cancers respond to immunotherapy
Diagnosis Recruiting nowThis phase I/II clinical trial evaluates if using a radiotracer targeting granzyme B, 64-copper granzyme targeting restricted interaction peptide specific to family member B (64 Cu-GRIP B) with positron emission tomography (PET) imaging can be safe and useful for detecting granzy…
Phase 1/2 • Sponsor: Rahul Aggarwal • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Can we predict dangerous blood clots in lymphoma patients? a major study aims to find out
Knowledge-focused CompletedComparative Evaluation of Thrombotic Risk Models in DLBCL patients Objective: To assess the impact of thrombotic risk factors and compare the performance of existing predictive models (Khorana, Throly, Model IX) in Diffuse Large B-cell Lymphoma (DLBCL) Primary Endpoints: Measu…
Sponsor: Fondazione IRCCS San Gerardo dei Tintori • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can tailored exercise help tame racing heart and fatigue after COVID?
Symptom relief OngoingCovid-19 has the potential to affect physical, cognitive and psychological functions in multiple ways. It has been clear that a significant proportion of patients with Covid-19 develop long-term symptoms. The term post COVID-19 condition (defined by WHO) is used to describe the w…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Ear-Zapping device may ease pain and opioid withdrawal
Symptom relief Recruiting nowThe purpose of the study is to find out how a stimulation device worn on the ear works. This device is thought to stimulate nerves in the area around the ear to change the signals in the brain. The device has been shown to reduce pain and to reduce the symptoms of withdrawal. The…
Sponsor: The University of Texas Medical Branch, Galveston • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Rural HPV vaccine push aims to prevent cancers
Prevention OngoingThis study evaluates the implementation of evidence based strategies to optimize HPV vaccination in rural primary care settings. Some of the largest disparities in human papillomavirus vaccination (HPVV) rates exist in rural communities, which represent missed opportunities for c…
Sponsor: Roswell Park Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
New combo could ease anemia for kidney patients on dialysis
Disease control Completedthis study aims to : 1. To compare the efficacy of combining low doses of Roxadustat Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase (PHD) inhibitor and iron versus standard treatment with erythropoietin-stimulating agents (ESA) in the treatment of anemia as a complication of …
Phase 4 • Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a new drug called ROSE12 help fight advanced solid tumors?
Disease control Recruiting nowThis is a Phase Ia/Ib open-label, dose-escalation study to evaluate the safety and pharmacokinetics of ROSE12 as a single agent and in combination with other anti-tumor agents in patients with locally advanced or metastatic solid tumors. The study will consist of three parts: a d…
Phase 1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a simple pastille stop mouth cancer before it starts?
Disease control Recruiting nowThe purpose of this study is to assess whether APG-157 can reduce the tumor size in participants with the study disease. Another purpose is to find out about the effects of APG-157 on certain tumor markers and oral rinses in participants with the study disease.
Phase 2 • Sponsor: Elizabeth J Franzmann • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New proton therapy could shrink skull tumor treatment to just 5 days
Disease control Recruiting nowThe project is planned as a phase II clinical trial with a low level of intervention, for the prospective evaluation of the clinical results of radical or adjuvant treatment by proton therapy in chordomas and chondrosarcomas of the skull base using hypofractionation schemes in 5 …
Sponsor: Quironsalud • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for men with early spread prostate cancer: shorter drug course may boost quality of life
Disease control Recruiting nowThis is a multi-centre, investigator-initiated, three-arm, randomized trial to investigate the addition on androgen receptor pathway inhibitor and atorvastatin to standard of care radiation and hormone therapy improve quality of life. Participants will either receive standard of…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug combo may reboot treatment for advanced liver cancer
Disease control CompletedThis study is a real-world, single-arm, observational study primarily collecting data on patients with hepatocellular carcinoma who experienced disease progression after receiving lenvatinib in combination with PD-1 inhibitors as part of routine clinical practice, and evaluating …
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Jun 26, 2026 19:15 UTC
-
Single radiation dose before surgery may improve brain tumor control
Disease control Recruiting nowThis phase I trial finds out the possible benefits and/or side effects of radiosurgery before surgery (preoperative) in treating patients with high grade glioma. Radiosurgery uses special equipment to position the patient and precisely give a single large dose of radiation to the…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Herbal hope: can ancient chinese medicine boost antidepressants?
Symptom relief CompletedStudy Title: Research on the therapeutic effect and clinical indicators of XingpiJieyu formula in the treatment of severe liver depression and spleen deficiency type depression based on abnormal mitochondrial energy metabolism pathway Purpose of the Study: (1) Application of XPJ…
Phase 4 • Sponsor: Peking University Sixth Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New drug FOG-001 takes on Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).
Phase 1/2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New study aims to predict concussion recovery in children using symptoms and biology
Knowledge-focused Recruiting nowThis project will measure concussion symptoms, biological markers, and academic and social factors across the first year postconcussion to develop a model that enables early identification of and symptom management for children at higher risk for persistent postconcussive symptom…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC